Expression and Localization of CYP3A4 and CYP3A5 in Human Lung

American Journal of Respiratory Cell and Molecular Biology

Volumn 16, Issue 3, 1997, Pages 242-249

  Anttila, Sisko ^a   Hukkanen, Janne ^b   Hakkola, Jukka ^b   Stjernvall, Tuula ^b   Beaune, Philippe ^b   Edwards, Robert J ^b   Boobis, Alan R ^b   Pelkonen, Olavi ^b   Raunio, Hannu ^b  

^a FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

NICOTIANA TABACUM;

CYP3A PROTEIN, HUMAN; CYP3A4 PROTEIN, HUMAN; CYP3A5 PROTEIN, HUMAN; CYTOCHROME P450; MESSENGER RNA; MIXED FUNCTION OXIDASE;

ARTICLE; BRONCHUS; CARCINOMA; CHEMISTRY; EPITHELIUM; FEMALE; GENE EXPRESSION; GENETICS; HUMAN; LUNG; LUNG ALVEOLUS MACROPHAGE; LUNG TUMOR; MALE; SMOKING; VASCULAR ENDOTHELIUM;

BRONCHI; CARCINOMA; CYTOCHROME P-450 ENZYME SYSTEM; ENDOTHELIUM, VASCULAR; EPITHELIUM; FEMALE; GENE EXPRESSION; HUMANS; LUNG; LUNG NEOPLASMS; MACROPHAGES, ALVEOLAR; MALE; MIXED FUNCTION OXYGENASES; RNA, MESSENGER; SMOKING;

EID: 0031092915     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.16.3.9070608     Document Type: Article

References (37)

1. Nelson, D. R., L Koymans, T. Kamataki, J. J. Stegeman, R. Feyereisen, D. J. Waxman, M. R. Waterman, O. Gotoh, M. J. Coon, R. W. Estabrook, I. C. Gunsalus, and D. W. Nebert. 1996. The P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 6:1-42.
2. Guengerich, F. P. 1993. Bioactivation and detoxication of toxic and carcinogenic chemicals. Drug Metab. Dispos. 21:1-6.
3. Shimada, T., M. V. Martin, D. Pruess-Schwartz, L. J. Marnett, and F. J. Guengerich. 1991. Roles of individual human cytochrome P-450 enzymes in the bioactivation of benzo(a)pyrene, 7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene, and other dihydrodiol derivatives of polycyclic aromatic hydrocarbons. Cancer Res. 49:6304-6312.
4. Roberts-Thomson, S. J., M. E. McManus, R. H. Tukey, F. J. Gonzalez, and G. M. Holder. 1993. The catalytic activity of four expressed human cytochromes P450s towards benzo(a)pyrene and the isomers of its proximate carcinogen. Biochem. Biophys. Res. Commun. 3:1373-1379.
5. Shou, M., K. R. Korzekwa, C. L. Crespi, F. J. Gonzalez, and H. V. Gelboin. 1994. The role of 12 cDNA-expressed human, rodent, and rabbit cytochromes P450 in the metabolism of benzo[a]pyrene and benzo[a]pyrene trans-7,8-dihydrodiol. Mol. Carcinogen. 10:159-168.
6. Gonzalez, F. J. 1992. Human cytochromes P450: problems and prospects. Trends Pharmacol. Sci. 13:346-352.
7. Raunio, H., M. Pasanen, J. Hakkola, J. Mäenpää, and O. Pelkonen. 1995. Extrahepatic expression of human P450s. In Advances in Drug Metabolism in Man. G. M. Pacifici and G. N. Fracchia, editors. Commission of the European Communities, Luxembourg. 234-287.
8. Wheeler, C. W., S. A. Wrighton, and T. M. Guenthner. 1992. Detection of human lung cytochromes P450 that are immunochemically related to cytochrome P450IIE1 and cytochrome P450IIIA. Biochem. Pharmacol. 44:183-186.
9. Kivistö, K. T., P. Fritz, A. Linder, G. Friedel, P. Beaune, and H. K. Kroemer. 1995. Immunohistochemical localization of cytochrome P450 3A in human pulmonary carcinomas and normal bronchial tissue. Histochemistry 103:25-29.
10. Kivistö, K. T., E.-U. Griese, P. Fritz, A. Linder, J. Hakkola, H. Raunio, P. Beaune, and H. K. Kroemer. 1996. Expression of cytochrome P4503A enzymes in human lung: a combined RT-PCR and immunohistochemical analysis of normal tissue and lung tumors. Naunyn-Schmied. Arch. Pharmacol. 353:207-212.
11. Kitada, M., and T. Kamataki. 1994. Cytochrome P450 in human fetal liver: significance and fetal-specific expression. Drug Metab. Rev. 26: 305-323.
12. Schuetz, J. D., D. L. Beach, and P. S. Guzelian. 1994. Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver. Pharmacogenetics 4:11-20.
13. Anttila, S., E. Hietanen, H. Vainio, A. M. Camus, H. V. Gelboin, S. S. Park, L. Heikkilä, A. Karjalainen, and H. Bartsch. 1991. Smoking and peripheral type of cancer are related to high levels of pulmonary cytochrome P450IA in lung cancer patients. Int. J. Cancer 47:681-685.
14. Anttila, S., A. Hirvonen, H. Vainio, K. Husgafvel-Pursiainen, J. D. Hayes, and B. Ketterer. 1993. Immunohistochemical localization of glutathione S-transferase in human lung. Cancer Res 53:5643-5648.
15. Belloc, C., S. Baird, J. Cosme, S. Lecoeur, J.-C. Gautier, D. Challine, I. de Waziers, J.-P. Flinois, and P. H. Beaune. 1996. Human cytochromes P450 expressed in Escherichia coli: production of specific antibodies. Toxicology 106:207-219.
16. Edwards, R. J., A. M. Singleton, B. P. Murray, D. S. Davies, and A. R. Boobis. 1995. Short synthetic peptides exploited for reliable and specific targeting of antibodies to the C-termini of cytochrome P450 enzymes. Biochem. Pharmacol. 49:39-47.
17. Devereux, J., P. Haeberli, and O. Smithies. 1984. A comprehensive set of sequence analysis programs for VAX and convex systems. Nucleic Acids Res. 12:387-395.
18. Gonzalez, F. J., B. J. Schmid, M. Umeno, O. W. McBride, J. P. Hardwick, U. A. Meyer, H. V. Gelboin, and J. R. Idle. 1988. Human p450PCN1: sequence, chromosome localization, and direct evidence through cDNA expression that p450PCN1 is nifedipine oxidase. DNA 7:79-86.
19. Aoyama, T., S. Yamano, D. J. Waxman, D. P. Lapenson, U. A. Meyer, V. Fischer, R. Tyndale, T. Inaba, W. Kalow, H. V. Gelboin, and F. J. Gonzalez. 1989. Cytochrome P-450 hPCN3, a novel cytochrome P-450 HIA gene product that is differentially expressed in adult human liver. cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCN1 and hPCN3 for the metabolism of steroid hormones and cyclosporine. J. Biol. Chem. 264:10388-10395.
20. Komori, M., K. Nishio, H. Ohi, M. Kitada, and T. Kamataki. 1989. Molecular cloning and sequence analysis of cDNA containing the entire coding region for human fetal liver cytochrome P-450. J. Biochem. 105: 161-163.
21. Schuetz, J. D., and P. S. Guzelian. 1995. Isolation of CYP3A5P cDNA from human liver: a reflection of a novel cytochrome P-450 pseudogene. Biochim. Biophys. Acta 1261:161-165.
22. Wrighton, S. A., W. R. Brian, M. A. Sari, M. Iwasaki, F. P. Guengerich, J. L. Raucy, D. T. Molowa, and M. VandenBranden. 1990. Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3). Mol. Pharmacol. 38:207-213.
23. Yamazaki, H., Y. Inui, S. A. Wrighton, F. P. Guengerich, and T. Shimada. 1995. Procarcinogen activation by cytochrome P450 3A4 and 3A5 expressed in Escherichia coli and by human liver microsomes. Carcinogenesis 16:2167-2170.
24. Howard, P. C., T. Aoyama, S. L. Bauer, H. V. Gelboin, and F. J. Gonzalez. 1990. The metabolism of 1-nitropyrene by human cytochromes P450. Carcinogenesis 11:1539-1542.
25. 1. Proc. Natl. Acad. Sci. USA 87:4790-4793.
26. Brian, W. R., M.-A. Sari, M. Iwasaki, T. Shimada, L. S. Kaminsky, and F. P. Guengerich. 1990. Catalytic activities of human liver cytochrome P-450 IIIA4 expressed in Saccharomvces cerevisiae. Biochemistry 29: 11280-11292.
27. Langenbach, R., P. B. Smith, and C. Crespi. 1992. Recombinant DNA approaches for the development of metabolic systems used in in vitro toxicology. Mutat. Res. 227:251-275.
28. Koehl, W., A. Amin, M. E. Staretz, Y.-F. Ueng, H. Yamazaki, T. Tateishi, F. P. Guengerich, and S. S. Hecht. 1996. Metabolism of 5-methylchrysene and 6-methylchrysene by human hepatic and pulmonary cytochrome P450 enzymes. Cancer Res. 56:316-324.
29. Kawajiri, K., K. Nakachi, K. Imai, J. Watanabe, and S.-I. Hayashi. 1993. The CYP1A1 and cancer susceptibility. Crit. Rev. Oncol. Hematol. 14: 77-87.
30. Anttila, S., A. Hirvonen, K. Husgafvel-Pursiainen, A Karjalainen, T. Nurminen, and H. Vainio. 1994. Combined effect of CYP1A1 inducibility and GSTMI polymorphism on histological type of lung cancer. Carcinogenesis 15:1133-1135.
31. Hakkola, J., M. Pasanen, J. Hukkanen, O. Pelkonen, J. Mäenpää, R. J. Edwards, A. R. Boobis, and H. Raunio. 1996. Expression of xenobiotic-metabolizing cytochrome P450 forms in human full-term placenta. Biochem. Pharmacol. 51:403-411.
32. Schuetz, E. G., J. D. Schuetz, S. C. Strom, M. T. Thompson, R. A. Fisher, D. T. Molowa, D. Li, and P. S. Guzelian. 1993. Regulation of human liver cytochromes P-450 in family 3A in primary and continuous culture of human hepatocytes. Hepatology 18:1254-1262.
33. Schuetz, J. D., E. G. Schuetz, J. V. Thottassery, P. S. Guzelian, S. Strom, and D. Sun. 1996. Identification of a novel dexamethasone responsive enhancer in the human CYP3A5 gene and its activation in human and rat liver cells. Mol. Pharmacol. 49:63-72.
34. Wrighton, S. A., B. J. Ring, P. B. Watkins, and M VandenBranden. 1989. Identification of polymorphically expressed member of the human cytochrome P-450III family. Mol. Pharmacol. 36:97-105.
35. Jounaidi, Y., P. S. Guzelian, P. Maurel, and M. J. Vilarem. 1994. Sequence of the 5′-flanking region of CYP3A5: comparative analysis with CYP3A4 and CYP3A7. Biochem. Biophys. Res. Commun. 205:1741-1747.
36. Schuetz, E. G., J. D. Schuetz, W. M. Grogan, A. Naray-Fejes Toth, G. Fejes-Toth, J. Raucy, P. Guzelian, K Gionela, and C. O. Watlington. 1992. Expression of cytochrome P450 3A in amphibian, rat, and human kidney. Arch. Biochem. Biophys. 294:206-214.
37. Kolars, J. C., K. S. Lown, P. Schmiedlin-Ren, M. Ghosh, C. Fang, S. A. Wrighton, R. M. Merion, and P. B. Watkins. 1994. CYP3A gene expression in human gut epithelium. Pharmacogenetics 4:247-259.